Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

AD Broyles, A Banerji, S Barmettler, CM Biggs… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Immediate and delayed hypersensitivity reactions to antibiotics: aminoglycosides, clindamycin, linezolid, and metronidazole

M Dilley, B Geng - Clinical Reviews in Allergy & Immunology, 2022 - Springer
Hypersensitivity reactions including IgE-mediated and delayed cell-mediated reactions to
aminoglycosides, clindamycin, linezolid, and metronidazole are rare. For aminoglycosides …

Trichomonas vaginalis: Clinical relevance, pathogenicity and diagnosis

T Edwards, P Burke, H Smalley… - Critical reviews in …, 2016 - Taylor & Francis
Trichomonas vaginalis is the etiological agent of trichomoniasis, the most prevalent non-viral
sexually transmitted disease worldwide. Trichomoniasis is a widespread, global health …

[HTML][HTML] Neglected parasitic infections in the United States: trichomoniasis

WE Secor, E Meites, MC Starr… - The American journal of …, 2014 - ncbi.nlm.nih.gov
Trichomonas vaginalis is one of the most common human parasitic infections in the United
States, as well as the most prevalent non-viral sexually transmitted infection. However, it has …

Metronidazole for the treatment of vaginal infections

R Sobel, JD Sobel - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: Metronidazole, undoubtedly the most widely known and used member of the
nitroimidazole drug class, remains not only first line therapy for bacterial vaginosis (BV) and …

Antimicrobial desensitization: a review of published protocols

DB Chastain, VJ Hutzley, J Parekh, JVG Alegro - Pharmacy, 2019 - mdpi.com
Antimicrobial desensitization represents a last-line option for patients with no alternative
therapies, where the benefits of this intensive process must outweigh the potential harm from …

Effect of Trichomonacide 6-Nitro-1H-benzimidazole Derivative Compounds on Expression Level of Metabolic Genes in Trichomonas vaginalis

JY Gutiérrez-Cardona, E Calderón-Jaimes… - International Journal of …, 2024 - mdpi.com
The parasite Trichomonas vaginalis is the etiologic agent of trichomoniasis, the most
common non-viral sexually transmitted disease worldwide. This infection often remains …

Drug allergies and implications for dental practice

DE Becker - Anesthesia progress, 2013 - meridian.allenpress.com
Adverse reactions to medications prescribed or administered in dental practice can be
worrying. Most of these reactions are somewhat predictable based on the pharmacodynamic …

Trichomonas vaginalis: treatment questions and challenges

WE Secor - Expert Review of Anti-infective Therapy, 2012 - Taylor & Francis
Full article: Trichomonas vaginalis: treatment questions and challenges Skip to Main Content
Taylor and Francis Online homepage Browse Search Publish Login | Register Log in or …

Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid

C Muzny, A Barnes, L Mena - Sexual health, 2012 - CSIRO Publishing
This report describes a patient with symptomatic Trichomonas vaginalis infection who was
unable to tolerate nitroimidazole drugs because of severe hypersensitivity, for which …